155 related articles for article (PubMed ID: 27172295)
21. Suspecting and Testing for Alpha-1 Antitrypsin Deficiency-An Allergist's and/or Immunologist's Perspective.
Craig TJ
J Allergy Clin Immunol Pract; 2015; 3(4):506-11. PubMed ID: 26032475
[TBL] [Abstract][Full Text] [Related]
22. Assessment of regional progression of pulmonary emphysema with CT densitometry.
Bakker ME; Putter H; Stolk J; Shaker SB; Piitulainen E; Russi EW; Stoel BC
Chest; 2008 Nov; 134(5):931-937. PubMed ID: 18625668
[TBL] [Abstract][Full Text] [Related]
23. Rationale and Design of the Genomic Research in Alpha-1 Antitrypsin Deficiency and Sarcoidosis Study. Alpha-1 Protocol.
Strange C; Senior RM; Sciurba F; O'Neal S; Morris A; Wisniewski SR; Bowler R; Hochheiser HS; Becich MJ; Zhang Y; Leader JK; Methé BA; Kaminski N; Sandhaus RA;
Ann Am Thorac Soc; 2015 Oct; 12(10):1551-60. PubMed ID: 26153726
[TBL] [Abstract][Full Text] [Related]
24. Lung clearance index for monitoring early lung disease in alpha-1-antitrypsin deficiency.
Fuchs SI; Schwerk N; Pittschieler K; Ahrens F; Baden W; Bals R; Fähndrich S; Gleiber W; Griese M; Hülskamp G; Köhnlein T; Reckling L; Rietschel E; Staab D; Gappa M
Respir Med; 2016 Jul; 116():93-9. PubMed ID: 27296827
[TBL] [Abstract][Full Text] [Related]
25. Prevalence and radiological outcomes of lung nodules in alpha 1-antitrypsin deficiency.
Subramanian DR; Edgar R; Ward H; Parr DG; Stockley RA
Respir Med; 2013 Jun; 107(6):863-9. PubMed ID: 23337299
[TBL] [Abstract][Full Text] [Related]
26. Relations between cardiopulmonary exercise testing and quantitative high-resolution computed tomography associated in patients with alpha-1-antitrypsin deficiency.
Schwaiblmair M; Beinert T; Seemann M; Behr J; Reiser M; Vogelmeier C
Eur J Med Res; 1998 Nov; 3(11):527-32. PubMed ID: 9810033
[TBL] [Abstract][Full Text] [Related]
27. The efficacy and safety of inhaled human α-1 antitrypsin in people with α-1 antitrypsin deficiency-related emphysema.
Franciosi AN; McCarthy C; McElvaney NG
Expert Rev Respir Med; 2015 Apr; 9(2):143-51. PubMed ID: 25598013
[TBL] [Abstract][Full Text] [Related]
28. Alpha 1-PI for emphysema due to alpha 1-antitrypsin deficiency.
Horowitz ID; Schulman ES
Am Fam Physician; 1989 Sep; 40(3):223-8. PubMed ID: 2672752
[TBL] [Abstract][Full Text] [Related]
29. [Two sisters with lung emphysema].
Piscaer I; Franssen FM; Ten Hacken NH; Wouters EF; Janssen R
Ned Tijdschr Geneeskd; 2016; 160():D497. PubMed ID: 27879179
[TBL] [Abstract][Full Text] [Related]
30. [Lack of effect of substitution therapy of alpha1-antitrypsin deficiency].
Dahl R; Hilberg O; Løkke A; Pedersen L; Ringbæk T; Titlestad I
Ugeskr Laeger; 2011 Oct; 173(42):2645-7. PubMed ID: 22027165
[TBL] [Abstract][Full Text] [Related]
31. The important role of primary care providers in the detection of alpha-1 antitrypsin deficiency.
Lascano JE; Campos MA
Postgrad Med; 2017 Nov; 129(8):889-895. PubMed ID: 28929906
[TBL] [Abstract][Full Text] [Related]
32. Immune activation in α1-antitrypsin-deficiency emphysema. Beyond the protease-antiprotease paradigm.
Baraldo S; Turato G; Lunardi F; Bazzan E; Schiavon M; Ferrarotti I; Molena B; Cazzuffi R; Damin M; Balestro E; Luisetti M; Rea F; Calabrese F; Cosio MG; Saetta M
Am J Respir Crit Care Med; 2015 Feb; 191(4):402-9. PubMed ID: 25412116
[TBL] [Abstract][Full Text] [Related]
33. [Expert statement for augmentation therapy in patients with alpha-1 antitrypsin deficiency].
Köhnlein T; Schmidt-Scherzer K; Greulich T; Bals R
Pneumologie; 2014 Jul; 68(7):492-5. PubMed ID: 25006842
[TBL] [Abstract][Full Text] [Related]
34. Design of a clinical trial to test a treatment of the underlying cause of emphysema.
Anthonisen N; Connett J; Friedman B; Glass M; Kilday DP; Mingo TS; Rudolphus A; Williams GW
Ann N Y Acad Sci; 1991 Dec; 624 Suppl():31-4. PubMed ID: 1686163
[No Abstract] [Full Text] [Related]
35. An unusual case of rapid radiological progression of bullous emphysema secondary to severe α1-antitrypsin deficiency.
Chew JR; Roy K; Babar J; Mahadeva R
BMJ Case Rep; 2015 May; 2015():. PubMed ID: 25953582
[No Abstract] [Full Text] [Related]
36. Exploring the role of CT densitometry: a randomised study of augmentation therapy in alpha1-antitrypsin deficiency.
Dirksen A; Piitulainen E; Parr DG; Deng C; Wencker M; Shaker SB; Stockley RA
Eur Respir J; 2009 Jun; 33(6):1345-53. PubMed ID: 19196813
[TBL] [Abstract][Full Text] [Related]
37. Augmentation therapy of alpha-1 antitrypsin deficiency associated emphysema.
Traclet J; Delaval P; Terrioux P; Mornex JF
Rev Mal Respir; 2015 Apr; 32(4):435-46. PubMed ID: 25908241
[TBL] [Abstract][Full Text] [Related]
38. [National cohort of patients with emphysema and alpha-1 antitrypsin deficiency].
Thabut G
Rev Mal Respir; 2005 Dec; 22(6 Pt 1):1053-7. PubMed ID: 16234760
[TBL] [Abstract][Full Text] [Related]
39. [Alpha-1 Antitrypsin Deficiency (AATD) - D-A-CH-Expert Statement].
Greulich T; Fähndrich S; Clarenbach C; Gleiber W; Hautmann H; Heine R; Idzko M; Schmidt-Scherzer K; Skowasch D; Wiewrodt R; Bals R; Koczulla AR
Pneumologie; 2020 Jul; 74(7):436-442. PubMed ID: 32492720
[No Abstract] [Full Text] [Related]
40. [Alpha-1-antitrypsin deficiency - an update].
Bernhard N; Bals R; Fähndrich S
Dtsch Med Wochenschr; 2016 Sep; 141(20):1467-1469. PubMed ID: 27701692
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
